Pharmacology HESI Comprehensive Examination Set 2 2026/2027 Complete Test Bank with NGN Style Case Studies and Verified Clinical Rationales Grade A

This Pharmacology HESI Comprehensive Examination (Set 2) resource is designed for nursing students in RN, PN, ADN, and BSN programs preparing for the HESI Pharmacology specialty exam and NCLEX pharmacology section for the 2026/2027 academic cycle. This represents Set 2 of a comprehensive test bank featuring Next Generation NCLEX (NGN) style questions incorporating case studies and scenario-based assessments . Each exam set contains multiple-choice questions with expert-verified explanations and solutions aligned with current HESI testing standards . The content delivers comprehensive coverage of high yield pharmacology concepts across multiple core domains including pharmacokinetics and pharmacodynamics, dosage calculations and safe administration, cardiovascular and hematologic agents, antimicrobial and antiviral therapy, endocrine and metabolic medications, neurological and psychotropic agents, gastrointestinal and renal pharmacology, and respiratory and immune system modifiers . Cardiovascular medications coverage includes digoxin for heart failure with therapeutic response assessment (decreased shortness of breath and decreased peripheral edema), digoxin toxicity monitoring with holding parameters for apical pulse below 60 bpm, furosemide IV push administration at maximum rate of 20 mg/min to prevent ototoxicity, warfarin with INR target of 2 to 3 and priority action for elevated INR (hold dose and notify provider before administering vitamin K), heparin with therapeutic aPTT target of 1.5 to 2.5 times control, protamine sulfate as heparin antidote, vitamin K as warfarin reversal agent, clopidogrel requiring discontinuation 5 to 7 days before elective surgery, nitroglycerin sublingual administration with the three tablet rule (take one, wait 5 minutes, if no relief take second, wait 5 minutes, take third and call 911), amiodarone requiring monitoring for pulmonary toxicity and corneal microdeposits, metoprolol as first line for chronic stable angina, and atorvastatin and rosuvastatin as high intensity statins for LDL reduction . Endocrine medications coverage includes rapid acting insulin lispro (Humalog) requiring meal timing coordination to prevent hypoglycemia due to onset within 15 minutes and peak around 1 hour, metformin associated with lactic acidosis requiring immediate discontinuation, levothyroxine therapy with administration early morning before breakfast, and corticosteroid long-term therapy monitoring for Cushingoid effects including hyperglycemia and mood changes . Anti infective and immunomodulator coverage includes TMP-SMX (Bactrim) combination therapy with synergistic mechanism reducing bacterial resistance, tetracycline absorption interference with sucralfate requiring staggered administration, rifampin causing body fluid discoloration, anti-infective therapy monitoring for superinfection signs including oral candidiasis (sore mouth), and theophylline therapeutic range of 10 to 20 mcg/mL with levels above indicating toxicity risk requiring dose hold and provider notification . Neurological and psychiatric medication coverage includes haloperidol (Haldol) for schizophrenia with extrapyramidal side effects including acute dystonia (jaw tightness and stiff neck) treated with diphenhydramine (Benadryl), carbamazepine requiring weekly blood testing to monitor for myelosuppression, phenobarbital overdose priority assessment of respiratory depression requiring vital signs assessment first, amitriptyline overdose treated with sodium bicarbonate to reverse QRS prolongation, and benztropine used to control extrapyramidal symptoms associated with antipsychotic therapy . Pain management and emergency medication coverage includes fentanyl with respiratory depression assessment, naloxone administration for opioid induced respiratory depression with priority intervention of administration and ventilation support, morphine PCA pump safety considerations, acetaminophen toxicity treatment with acetylcysteine, opioid use caution in COPD patients, and ibuprofen patient teaching requiring avoidance of concurrent aspirin use due to bleeding risk . Medication administration safety coverage includes the rights of medication administration, high alert medications requiring special safeguards, sublingual nitroglycerin administration protocol, transdermal analgesic administration for continuous pain control, IM injection technique, factors increasing adverse reaction risk including advanced age and liver disease, and herbal supplement teaching including ginkgo biloba limitations during pregnancy and interaction with antiplatelet medications . Each question includes detailed clinical rationales explaining correct answer selection, mechanism of action, adverse effect identification, nursing intervention prioritization, and distractor analysis as outlined in HESI testing guidelines and NGN standards . Aligned with current HESI and NCLEX certification standards for 2026/2027, this comprehensive test bank enhances exam readiness, reinforces pharmacological clinical judgment skills, and builds confidence for HESI Pharmacology specialty examination success on the first attempt with HESI required passing score standards . Keywords Pharmacology HESI Comprehensive Examination Set HESI pharmacology test bank NGN style case studies cardiovascular medications digoxin therapeutic response decreased edema digoxin toxicity monitoring apical pulse below 60 bpm hold dose furosemide IV push rate 20 mg per minute ototoxicity prevention warfarin INR target 2 to 3 hold dose notify provider heparin aPTT therapeutic 1.5 to 2.5 times control protamine sulfate heparin antidote vitamin K warfarin reversal clopidogrel surgery discontinuation 5 to 7 days pre operative nitroglycerin sublingual three tablet rule 5 minutes call 911 amiodarone pulmonary toxicity corneal deposits monitoring metoprolol first line chronic stable angina beta blocker rosuvastatin high intensity statin LDL reduction 50 percent insulin lispro Humalog meal timing hypoglycemia prevention metformin lactic acidosis discontinuation priority action levothyroxine morning administration before breakfast corticosteroid Cushingoid effects hyperglycemia mood changes TMP SMX Bactrim synergistic bacterial resistance prevention tetracycline sucralfate interaction absorption interference superinfection oral candidiasis sore mouth antibiotic therapy theophylline therapeutic range 10 to 20 mcg per mL toxicity haloperidol Haldol acute dystonia jaw tightness stiff neck diphenhydramine Benadryl EPS treatment anticholinergic carbamazepine weekly blood tests myelosuppression monitoring phenobarbital overdose respiratory depression vital signs priority amitriptyline overdose sodium bicarbonate QRS prolongation benztropine extrapyramidal symptom control antipsychotic naloxone opioid respiratory depression ventilation support acetaminophen toxicity acetylcysteine antidote ibuprofen aspirin concurrent use bleeding risk contraindication ginkgo biloba pregnancy limitation antiplatelet interaction high alert medication safeguards six rights administration transdermal analgesic continuous pain control cancer pain adverse reaction risk factors advanced age liver disease pharmacokinetics pharmacodynamics dosage calculations HESI Next Generation NCLEX pharmacology case scenarios HESI pharmacology passing score guarantee RN PN HESI pharmacology test bank set 2 review